As Peptides Go Mainstream, CeliaRx Aims To Cut Through The Noise
✨ AI Summary
🔊 جاري الاستماع
LeadershipForbesWomenAs Peptides Go Mainstream, CeliaRx Aims To Cut Through The NoiseByGabby Shacknai,Contributor.Forbes contributors publish independent expert analyses and insights. I write about the beauty and wellness space and the women shaping it.Follow AuthorJun 03, 2026, 02:44pm EDT--:-- / --:--This voice experience is generated by AI. Learn more.This voice experience is generated by AI. Learn more.With demand for personalized wellness solutions on the rise, CeliaRx is helping bring peptide therapy to a broader audience through a physician-guided telehealth platform.Courtesy of CeliaRxJust a few years ago, peptides were largely confined to the niche realms of biohackers, longevity enthusiasts, and a small circle of functional medicine practitioners. As consumers increasingly seek proactive approaches to health and longevity, however, the category has rapidly moved from the fringes of wellness into the mainstream, and peptides have emerged as one of the industry's fastest-growing sectors, driving conversations around recovery, metabolic health, skin rejuvenation, hormone optimization, and healthy aging.Koehl Robinson has watched that evolution happen in real time. As interest around longevity, recovery, and proactive health optimization gained momentum, she saw consumers struggling to make sense of a rapidly expanding and often confusing peptide market. Sensing both a growing demand and a gap in trusted guidance, the entrepreneur and longevity advocate created CeliaRx, a telehealth platform designed to help bring physician-guided peptide care to a broader audience.The company offers physician-guided peptide protocols through a streamlined digital platform, allowing patients to complete an intake, consult with licensed providers, receive personalized recommendations, and have treatments delivered directly to their homes. The larger goal, Robinson says, is to remove some of the confusion surrounding a category that has exploded in popularity but remains po...




